Gassert Chad
SEC CIK 1871002 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANIP | ANI PHARMACEUTICALS INC | SVP - CORP. DEV, STRATEGY | 74.9K | $275.1K | $15.14M | 22 | 2021-11-19 | 2026-02-28 |
Most active insiders at ANIP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lalwani Nikhil | Pres, CEO, Dir | — | $5.05M |
| 2 | Walsh Patrick D | Dir | — | $2.32M |
| 3 | CAREY STEPHEN P. | SVP, CFO | — | $1.78M |
| 4 | Mutz Christopher | HEAD OF RARE DISEASE | — | $1.64M |
| 5 | Gassert Chad | SVP - CORP. DEV, STRATEGY | — | $1.31M |
| 6 | Davis Krista | SVP, Chief HR Off | — | $918.6K |
| 7 | Gutwerg Ori | SVP, GENERICS | — | $621.4K |
| 8 | Cook Meredith | SVP, GC, SEC | — | $453.9K |
| 9 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | — | $393.8K |
| 10 | HAUGHEY THOMAS | Dir | — | $161.8K |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | 2026-02-26 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | A - Grant | $77.15 | +11.1K | 77.1K | +17% | +$857.6K | |
| 2026-03-02 | 2026-02-28 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | F - Tax | $73.90 | -2,221 | 74.9K | -3% | -$164.1K | |
| M | 2026-02-17 | 2026-02-12+ | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | F - Tax | $77.04 | -3,325 | 66.0K | -5% | -$256.2K |
| 2026-02-13 | 2026-02-11 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | F - Tax | $76.25 | -4,269 | 69.3K | -6% | -$325.5K | |
| MI | 2025-11-14 | 2025-11-12+ | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | S - Sale | $89.06 | -14.7K | 158.5K | -9% | -$1.31M |
| I | 2025-08-18 | 2025-08-15 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | S - Sale | $86.97 | -20.0K | 173.2K | -10% | -$1.74M |
| M | 2025-02-18 | 2025-02-12 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | A - Grant | $0.00 | +23.9K | 64.0K | +60% | $0 |
| I | 2024-07-02 | 2024-07-01 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | S - Sale | $63.44 | -20.0K | 193.2K | -9% | -$1.27M |
| I | 2024-06-04 | 2024-06-03 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | S - Sale | $64.41 | -20.0K | 213.2K | -9% | -$1.29M |
| I | 2024-05-03 | 2024-05-01 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | S - Sale | $66.62 | -20.0K | 233.2K | -8% | -$1.33M |
| I | 2024-04-02 | 2024-04-01 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | S - Sale | $67.25 | -20.0K | 253.2K | -7% | -$1.34M |
| I | 2024-03-13 | 2024-03-11 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | S - Sale | $65.81 | -20.0K | 273.2K | -7% | -$1.32M |
| 2024-03-01 | 2024-02-29 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | F - Tax | $67.67 | -1,635 | 49.7K | -3% | -$110.6K | |
| M | 2024-02-16 | 2024-02-14 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | A - Grant | $0.00 | +22.4K | 51.3K | +77% | $0 |
| I | 2023-10-03 | 2023-10-02 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | S - Sale | $56.48 | -20.0K | 293.2K | -6% | -$1.13M |
| I | 2023-09-05 | 2023-09-01 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | S - Sale | $64.70 | -20.0K | 313.2K | -6% | -$1.29M |
| I | 2023-08-03 | 2023-08-01 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | S - Sale | $51.06 | -20.0K | 333.2K | -6% | -$1.02M |
| I | 2023-07-06 | 2023-07-03 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | S - Sale | $53.43 | -20.0K | 353.2K | -5% | -$1.07M |
| I | 2023-06-23 | 2023-06-22 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | S - Sale | $51.32 | -20.0K | 373.2K | -5% | -$1.03M |
| M | 2023-04-04 | 2023-02-28 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | A - Grant | $0.00 | +28.9K | 28.9K | New | $0 |
| MI | 2022-03-22 | 2022-03-18+ | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | P - Purchase | $27.51 | +10.0K | 393.2K | +3% | +$275.1K |
| I | 2021-11-23 | 2021-11-19 | ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV, STRATEGY | A - Grant | — | +383.2K | 383.2K | New | — |
Purchase Sale Sale after option exercise All abbreviations